EL
TMO icon

Essex LLC’s Thermo Fisher Scientific TMO Stock Holding History

Essex LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Sell
559
-50
-8% -$24K 0.04% 152
2026
Q1 		$300K Buy
609
+1
+0.2% +$543 0.05% 146
2025
Q4 		$353K Sell
608
-21
-3% -$11.9K 0.06% 135
2025
Q3 		$305K Buy
629
+7
+1% +$3.26K 0.06% 144
2025
Q2 		$252K Sell
622
-50
-7% -$20.9K 0.05% 154
2025
Q1 		$335K Sell
672
-50
-7% -$27.1K 0.07% 119
2024
Q4 		$376K Hold
722
– – 0.08% 117
2024
Q3 		$447K Sell
722
-7
-1% -$4.14K 0.09% 112
2024
Q2 		$403K Sell
729
-2
-0.3% -$1.15K 0.09% 113
2024
Q1 		$425K Hold
731
– – 0.1% 105
2023
Q4 		$388K Buy
731
+110
+18% +$53.2K 0.1% 111
2023
Q3 		$314K Buy
621
+5
+0.8% +$2.66K 0.09% 120
2023
Q2 		$321K Sell
616
-31
-5% -$16.7K 0.09% 116
2023
Q1 		$356K Hold
647
– – 0.11% 113
2022
Q4 		$356K Hold
647
– – 0.11% 113
2022
Q3 		$328K Sell
647
-44
-6% -$24.6K 0.11% 112
2022
Q2 		$375K Sell
691
-81
-10% -$44.6K 0.12% 113
2022
Q1 		$456K Sell
772
-98
-11% -$56.3K 0.12% 119
2021
Q4 		$580K Sell
870
-39
-4% -$24.4K 0.16% 109
2021
Q3 		$519K Buy
+909
New +$499K 0.14% 111

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Essex LLC's TMO Position: Q2 2026 in Review

Essex LLC reduced its Thermo Fisher Scientific (TMO) stake by 8.2% in Q2 2026, selling an estimated $24K and leaving 559 shares worth $280K. The position accounts for 0.04% of the portfolio, ranked #152.

Essex LLC first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $580K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Essex LLC held 559 shares of Thermo Fisher Scientific worth $280K as of Q2 2026.
  • Essex LLC sold 50 Thermo Fisher Scientific shares in Q2 2026, an estimated $24K.
  • Thermo Fisher Scientific made up 0.04% of Essex LLC's portfolio in Q2 2026, its #152 holding.
  • Essex LLC first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
  • Essex LLC's Thermo Fisher Scientific position peaked at $580K in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.